Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Icogen's Chemokine Research Receives $1M SBIR Award

Feb. 6, 2003

By Aaron Lorenzo

TransTech Translates Progress Into $24.5M Secured Investment

Feb. 5, 2003

By Aaron Lorenzo

MaxCyte, Northern Therapeutics Enter Gene Therapy Delivery Deal

Feb. 5, 2003

By Aaron Lorenzo

MaxCyte, Northern Therapeutics Enter Gene Therapy Delivery Deal

Feb. 5, 2003

By Aaron Lorenzo

TransTech Translates Progress Into $24.5M Secured Investment

Feb. 5, 2003

By Aaron Lorenzo

Abgenix, Chugai Collaborate On Human Antibody Therapies

Feb. 4, 2003

By Aaron Lorenzo

Pharmacopeia Enters Two Deals, Receives Milestone From Another

Feb. 4, 2003

By Aaron Lorenzo

Abgenix, Chugai Collaborate On Human Antibody Therapies

Feb. 4, 2003

By Aaron Lorenzo

Pharmacopeia Enters Two Deals, Receives Milestone From Another

Feb. 4, 2003

By Aaron Lorenzo

Texas Biotechnology Regaining Rights To PAH Drug From ICOS

Feb. 3, 2003

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...